select a format

Single User License
USD 2500 INR 160350
Site License
USD 5000 INR 320700
Corporate User License
USD 7500 INR 481050

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Liposarcoma Global Clinical Trials Review, H1, 2015

Liposarcoma Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2567CTIDB
  • |
  • Pages: 77
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Liposarcoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Liposarcoma 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Liposarcoma to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Liposarcoma to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Liposarcoma 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Liposarcoma Therapeutics Clinical Trials 31

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Pfizer Inc. 33

Clinical Trial Overview of Pfizer Inc. 33

Zeltia, S.A. 34

Clinical Trial Overview of Zeltia, S.A. 34

Johnson & Johnson 35

Clinical Trial Overview of Johnson & Johnson 35

F. Hoffmann-La Roche Ltd. 36

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36

Novartis AG 37

Clinical Trial Overview of Novartis AG 37

Merck & Co., Inc. 38

Clinical Trial Overview of Merck & Co., Inc. 38

Sanofi 39

Clinical Trial Overview of Sanofi 39

Daiichi Sankyo Company, Limited 40

Clinical Trial Overview of Daiichi Sankyo Company, Limited 40

Clinical Trial Overview of Top Institutes / Government 41

National Cancer Institute 41

Clinical Trial Overview of National Cancer Institute 41

European Organization for Research and Treatment of Cancer 42

Clinical Trial Overview of European Organization for Research and Treatment of Cancer 42

Fred Hutchinson Cancer Research Center 43

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 43

Memorial Sloan Kettering Cancer Center 44

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 44

University of Heidelberg 45

Clinical Trial Overview of University of Heidelberg 45

Institut Bergonie 46

Clinical Trial Overview of Institut Bergonie 46

Grupo Espanol de Investigacion en Sarcomas 47

Clinical Trial Overview of Grupo Espanol de Investigacion en Sarcomas 47

Northwestern University 48

Clinical Trial Overview of Northwestern University 48

Children's Oncology Group 49

Clinical Trial Overview of Children's Oncology Group 49

Five Key Clinical Profiles 50

Appendix 75

Abbreviations 75

Definitions 75

Research Methodology 76

Secondary Research 76

About GlobalData 77

Contact Us 77

Disclaimer 77

Source 77

List of Figures

Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 76

List of Tables

Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015* 7

Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Liposarcoma Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Liposarcoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Liposarcoma Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeltia, S.A., 2015* 34

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 35

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 36

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 38

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 39

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 40

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 41

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 42

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 43

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 44

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2015* 45

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Bergonie, 2015* 46

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Investigacion en Sarcomas, 2015* 47

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 48

Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2015* 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Liposarcoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Liposarcoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com